Addressing the Billions Underserved

Featured in

Pfizer Fights Patent Losses With Divestments

110Pfizer Inc (PFE), the world’s biggest pharmaceutical company, posted an enormous increase in quarterly profits from $1.4 billion in Q4-2011 to $6.3 billion in Q4-2012 because of the $11.85 billion cash sale of its infant nutrition unit to Nestle. Pfizer completed the sale in November and booked the whole gain of $4.83 billion. The company was also able to lower its costs and expenses and as a result performed better than analysts’ estimates. Excluding one-off items, Pfizer’s adjusted quarterly earnings were $3.52 billion or $0.47 per share which off 6.9% year over year. The company is still recuperating from the loss of patent of some of its best drugs such as Geodon, Xalatan and, of course, Lipitor.

Read the rest at Seeking Alpha.

The Most Important Capital Shift of the Century

Because of titanic changes in the global economy led by China’s ascension we have dug deep to find 3 places set to expand the most from China’s expansion westward and the shocking U.S. attempts to contain them in the great global race to control the major strategic resources in the 21st century. Click below to sign up and find out more…

Leave a Reply

Peter Pham is an author, international fund manager, and a registered financial director by the Cayman Monetary Authority (CIMA). In 2013 he published his first book entitled, The Big Trade: Simple Strategies for Maximum Market Returns. He currently manages the portfolio of a global hedge fund and runs an asset management company, Phoenix Capital.  (read more)

StockTwits Follow Peter Pham on StockTwits Follow Peter Pham on Twitter Follow StockTwits on Facebook Subscribe to AlphaVN RSS

The Big Trade: Simple Strategies for Maximum Market Returns

Sign Up for AlphaVN Reports

Site Archive

Page 1 of 11